Recently, several laboratories have derived monoclonal antibodies (mAb) 1 that react with clonotypic determinants of the heterodimeric antigen receptor molecules expressed on human (1-6) and murine T cells (7) (8) (9) (10) (11) (12) . In some instances these antibodies (also referred to as anti-Ti) mimic the effect of specific antigens by inducing proliferation of and lymphokine release by T lymphocytes expressing the corresponding clonotype (1, 4, 13). On the other hand, antibodies to the monomorphic T3 molecules are also able to induce T cell proliferation and lymphokine release, but this effect is not clonotypically restricted (13) (14) . In addition, soluble anti-T3 antibody blocks antigen-induced specific T cell stimulation (13) as well as specific target cell lysis by cytolytic T lymphocytes (15-19). The effects of anti-T3 antibody have been explained by the fact that T3 molecules are physically and functionally linked to the Ti-bearing receptor molecules (20) . Recently (21, 22), however, some antibodies directed against the T11 molecule, which is physically unrelated to the Ti-T3 complex, have also been shown to activate T cells leading to cell proliferation and lymphokine release. In the present study we have analyzed a third nonclonotypic molecule (designated T44) that appears to be involved in human T cell activation. T44 has been recently defined by the 9.3 mAb as a T-specific (23) surface glycoprotein of approximately Mr 44,000 (44 K) (24). The 9.3 antibody has been reported (25) to enhance the proliferative responses to phytohemagglutinin or to allogeneic cells, but to have no effect on resting T lymphocytes. Here we show that the 9.3 (anti-T44) mAb, in the presence of adherent cells, can directly induce human peripheral blood T lymphocytes to proliferate and release interleukin 2 (IL-2). The availability of a variant of the 1L-2-produc!ng Jurkat leukemia cell line (termed JA3), and of four corresponding anticlonotypic antibodies, allowed a better analysis of the molecular and functional characteristics of this molecule and its relationship with Ti, T3, and T11 structures. Thus, upon interaction with the anti-T44 mAb, T44 molecules underwent rapid modulation from the This work was supported in part by grants to G. Pantaleo from the Italian CNR (P. R. Oncologia).
Nonidet P-40 (NP-40), i mg/ml bovine serum albumin, and 0.1 mM phenylmethylsulphonyl fluoride (PMSF), for 90 min at 4°C. After spinning at 100,000 g, the supernatant was then immunoprecipitated as follows. Supernatants were dialyzed with PBS containing 0.05% NP-40 and 0.1 mM PMSF and precleared three times with 100 #1 of packed protein A-Sepharose beads for 2 h under rotation. Aliquots (900 ~1) were then incubated for 2 h with 20 ~1 of a 1:10 dilution of anti-T44 (9.3) mAb or 10 #1 of anti-Ti (JTi4) ascite diluted 1:50.20 #1 of protein A-Sepharose beads were then added and samples incubated for 4 h at 4°C. The immunoprecipitate was eluted from protein A-Sepharose by boiling for 2 min in 5% sodium dodecyl sulfate (SDS) in the presence or absence of 5% 2-mercaptoethanol and analyzed on 11% discontinuous SDS-polyacrylamide gels (33) .
For absorption studies, after incubation with the packed anti-T44 (or anti-JTi4) mAbspecific immunoabsorbent, the cell lysate was reincubated twice with the same immunoabsorbent, following the procedure described above. Using this protocol, virtually complete depletion of the corresponding T44 (or JTi) molecules was achieved. The resulting "cleared" cell lysate was then incubated with the anti-JTi (or anti-T44) mAb-specific immunoabsorbent for an additional 3 h at 4 ° C. After washing, the specific bound material was eluted and separated by SDS-PAGE as described above.
Flow Cytofluorometric Analysis. The techniques used have been described in detail elsewhere (34). Briefly, aliquots of 105 cells (peripheral lymphocytes, MLC-induced blast cells, thymocytes, or JA3 cells) were stained with the appropriate mAb followed by fluoresceinated goat anti-mouse Ig. Control aliquots were stained with the fluorescent reagent alone. All samples were then analyzed on a flow cytometer (FACS II; Becton Dickinson Immunocytometry Systems, Mountain View, CA) gated to exclude nonviable cells. Results are expressed as arbitrarily normalized fluorescence histograms, i.e., number of cells vs. fluorescence intensity.
Proliferation of PB T Lymphocytes in Response to mAb or Phytohemagglutinin (PHA).
Proliferative responses of PB T lymphocytes to mAb or PHA were analyzed as follows. T lymphocytes (or unfractionated PBMNC) were cultured as described elsewhere (31) in triplicate microwells (105 cells/well) (Greiner Labor Technik, Nurtinger, FRG) either alone or with 1-2 × 104 adherent cells in 0.2 ml with RPMI 1640 supplemented with 10% fetal calf serum (FCS) (Gibco Laboratories, Grand Island, NY), L-glutamine, penicillin-streptomycin, and one or another stimulus, for varying culture intervals. PHA was used at a final dilution of 1:100. mAb were used at the following dilutions: Leu-4 mAb, 1:100 to 1:1000 of the stock solution; 9.3 mAb, 1:40 to 1:500 of the stock solution; 3A 1, 4F2, and U CHT 1 mAb, i:i 000 dilution of ascitis. After incubation at 37 °C in a 6% COs, humidified atmosphere for different culture intervals, individual wells were pulsed with 1 #Ci of [SH] 
Determination of IL-2 Production by Peripheral T Lymphocytes.
To evaluate the amount of IL-2 produced by lymphocytes after stimulation with lectin or mAb, we used a murine T cell proliferation assay as described (35) . Briefly, peripheral blood lymphocytes (105) were cultured for varying periods of time in the presence of one or another stimulus (see above) under the same culture conditions mentioned above. In experiments performed to study the effect of modulation of T3 or T44 antigens on the subsequent antibodyinduced IL-2 production, "modulated" or "unmodulated" purified T lymphocytes were cultured (105 per well) in the presence of mAb and 104 adherent cells for 48 h before collection of culture supernatants. 100 #1 of culture supernatants were removed from each microculture and added at a final concentration of 50% to 4 x 105 murine indicator cells (CTLL line, kindly provided by Dr. K. Smith [36] ). IL-2 activity was assessed by [5H]TdR uptake by CTLL after a 6 h pulse with 1 #Ci of [3H]TdR at the end of a 24 h culture period.
Determination oflL-2 Production byJA3. To quantitate the amount of IL-2 secreted by JA3 cells after stimulation with mitogen or mAb, JA3 cells (1.5 × 105 per well) were cultured in the presence of phorbol myristate acetate (PMA) (10 ng/ml) or 104 adherent cells and one or another stimulus for a 24 h period. Thereafter, 100 #l of supernatant were removed and assessed for IL-2 activity on the murine CTL line, as previously described (35) . PHA was used at a final dilution of 1:100; Leu-4 and 9.3 mAb, 1:200 to 1:500; 3A1 and 4F2 mAb, 1:t000 dilution of ascitis; UCHT-1 mAb, 1:5000 dilution of ascitis; JTi] and JTi4 mAb, 1 : 10 dilution of the hybridoma culture supernatant.
Modulation Experiments. Antigenic modulation of JA3 cells or purified T cells was performed by addition of one or another mAb and incubation for 24 h at 37°C in 6% CO2. To ensure that modulation was performed in the presence of a saturating amount of mAb, a large antibody excess was used. Cells were cultured in flat-bottomed wells (Costar, Data Packaging, Cambridge, MA) at a concentration of 106/ml in RPMI 1640 (Seromed, Biochrom, FRG), 10% FCS, with the following final dilutions of mAb: Leu-4 and 9.3, 1:100 of the stock solution; 3A1, MAR 206 (anti-T11), 4F2, UCHT1 (anti-T3), JTi], and JTi~ mAb, 1:100 of the ascitic fluid. After modulation at 37°C for 24 h, cells were harvested, washed twice, and either stained directly with fluorescent anti-mouse antibodies or incubated with one or another mAb followed by the fluorescent anti-mouse reagent (17) . The percentage of modulation as well as the percentage of reexpression of the various surface molecules was calculated according to Reinherz et al. (37) . The same experimental procedure was used in experiments in which cells were stimulated with mAb and PMA (or adherent cells) after antigen modulation (see above).
Results

Functional Consequences of T44 Triggering of Peripheral Blood T Lymphocytes:
Induction of Cell Proliferation and IL-2 Release. Prior studies (25) indicated that anti-T44 antibody specifically reacted with human T lmphocytes and enhanced the proliferative responses to PHA or to allogeneic cells, whereas no effect was observed on unstimulated lymphocytes. In view of the potential importance of T44 molecules in T cell activation, we investigated the ability of anti-T44 mAb to induce lymphocyte proliferation, in comparison with anti-T3 antibody or PHA. First, the distribution of T44 antigen in different T cell populations was investigated. Fig. 1 shows the reactivity pattern of anti-T44 or anti-T3 antibody with peripheral blood lymphocytes, thymocytes, and T cells activated in 7-d MLC. In adherent cell-depleted peripheral blood lymphocytes, a large proportion of cells (65-75%) was T44 positive. In addition, the fluorescence distribution was clearly bimodal (Fig. 1 A) , similar to that observed with anti-T3 antibody (Fig. 1D ). In addition, sequential staining with anti-T44 and anti-T3 antibody (and vice versa) did not lead to any increase in the percentages of stained cells, indicating that T44 and T3 antigen were largely, if not totally, expressed by the same cells. Virtually 100% of T cells activated in 7-d mixed lymphocyte culture expressed both T44 and T3 antigen (Fig. 1, B and E). In contrast, only minor subsets of thymocytes expressed T44 or T3 antigen (C and F). In several experiments, the percentages of T44 + thymocytes were 10-20%. mAb directed to T3 molecules have been shown (21) to promote polyclonal proliferation of resting T lymphocytes provided that monocytes are present in the culture assay. The mitogenic potential of anti-T44 mAb under culture conditions giving optimal responses to anti-T3 was then examined. The anti° T44 mAb was compared with PHA and anti-T3 and 3-A1 mAb for the capacity to induce proliferation of peripheral blood T cells in the presence of 10-20% adherent cells. As shown in Fig. 2A , anti-T44 mAb had a strong mitogenic effect, comparable in magnitude to that obtained with anti-T3 antibody or PHA. However, unlike T cell proliferation with PHA or anti-T3 mAb, that induced by 9.3 mAb was maximal at day 5 of culture instead of day 3. Like anti-T3, anti-T44 antibody required macrophages to mediate this mitogenic effect. Comparable results were obtained with 10 other donors (data not shown). The efficient T cell proliferation obtained with anti-T44 antibody could be mediated via IL-2 production by the responding T cell populations. To determine whether anti-T44 antibody was indeed capable of inducing IL-2 release, the same cell culture combinations analyzed in proliferation assays were tested for IL-2 release. In these experiments, culture supernatants were collected at different intervals and analyzed for IL-2 activity by a proliferation assay, using the CTLL cells as an indicator system (36) . Anti-T44 antibody did induce IL-2 production ( anti-T3 was maximal at 24 h, it peaked at 48 h in cultures induced with anti-T44.
Derivation of ClonotypicaUy Restricted Antibodies Stimulating IL-2 Production from the T44-positiveJA3
Cell Line. Analysis of the physical and functional relationship between T44 molecule and other surface molecules involved in T cell activation, including the clonotypically restricted Ti and the monomorphic T3 or T11 molecules, required the availability of an appropriate IL-2-producing T cell clone or tumor T cell line and anticlonotypic antibodies selectively reactive with such cells. We recently derived by mutagenesis a variant of the Jurkat leukemic T cell line, designated JA3 (surface phenotype: Tll ÷, T3 +, 3A1 +, T4-, T8-, DR-, TAC-, 4F2 +, T44+), which produces large amounts of IL-2 upon stimulation with PHA or with anti-T3 mAb in conjunction with PMA or adherent cells. To produce mAb against clonotypic structures of JA3 cells, we used these cells to immunize BALB/c mice. Subsequently, immune splenocytes were fused with P3-U1 mouse myeloma line by standard hybridization techniques. Supernatants of the 372 individual hybridomas were screened according to their ability to induce JA3 to produce IL-2 in the presence of PMA. By this screening procedure, we selected four stimulatory mAb that reacted with JA3 but lacked reactivity with any other T tumor cell line tested, with resting or activated T cell populations and several T cell clones, as assessed by indirect immunofluorescence on a FACS. These antibodies were termed anti-JTil, -JTi2, -JTi3, and -JTi4 and were of the IgG2a (JTil_3) and IgG2b (JTi4) murine isotype, respectively. JTil_4 antibodies were shown to immunoprecipitate in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) a single diffuse band of 85 K Mr under nonreducing conditions and two major peptides of Mr 40 and 45 K under reducing conditions (see below). In some experiments, however, a third band could be visualized under reducing conditions. In this respect it should be noted that anti-Ti mAb directed against T cell clones (1), T cell lines such as REX (38) or HPB-ALL (2, 5), or T cell leukemias (3, 4) usually precipitate only two bands under reducing conditions. However, our results are in line with the data reported by Weiss and Stobo (6), who used an anti-Ti mAb directed against a nonmutagenized Jurkat clone. In addition, cross-inhibition and sequential immunoprecipitation experiments provided clear evidence that anti-JTil_4 reacted with the same surface molecule on JA3 cells. The reactivity pattern of the antibodies, their functional properties, and the characteristics of the immunoprecipitated molecules clearly indicate that JTij_4 recognize cionotypic determinants of the T cell receptor molecule. While further characteristics of JTil_4 antibodies have been described elsewhere (Moretta, Pantaleo, Lopez-Botet, and Moretta, submitted for publication), here such anticlonotypic antibodies were used as a tool for analysis of the physical and functional relationship between T44 molecules and the T3-Ti molecular complex.
Anti-T44 Antibody Immunoprecipitates a Prevalent Mr 80 K Band Under Nonreducing Conditions.
The molecule immunoprecipitated by the 9.3 antibody was originally termed T44 on the basis of the apparent Mr under reducing conditions (24) . The molecule precipitated by the same anti-T44 antibody on JA3 cells appeared (Fig. 3B) as a diffuse band of Mr 40-45 K under reducing conditions. In addition, a second band of 80-85 K could be seen. Moreover, under nonre- Table I , PHA and antibodies to T 3 , JTi, or T 4 4 molecules induced production of large amounts of IL-2 in the presence of PMA. Antibodies directed against other antigens expressed by JA3 such as 3A1 and 4F2 (30), used as controls, had no stimulatory effect. Although not shown, similar results were obtained in the presence of adherent cells without the addition of PMA. It is noteworthy that lower but significant IL-2 production f r o m J A 3 was also detected with anti-T44 mAb in the absence of both PMA and adherent cells, whereas no proliferative response by resting T cells was observed under the same conditions.
Independent Expression of T44 Molecules and T3-Ti Receptor
Complex at the T Cell Surface. T 4 4 molecules display an Mr similar to that of T cell receptor ino~ecules u n d e r both reducing and nonreducing conditions. This, together with the common ability of the two structures to trigger T cell proliferation and IL-2 release, suggested a possible molecular relationship between the two molecules. Antibodies directed to the T3 or Ti structures have been shown (13) to induce modulation of the corresponding molecules. In addition, modulation of either one of the two molecules resulted in comodulation of the other. In agreement with these data, anti-T3 or anti-JTi mAb induced complete modulation of T3-Ti molecular complex in JA3 cells (Fig. 4) . Given the ability of anti-T44 antibody to induce IL-2 production in a similar manner as anti-T3 or anti-JTi antibody, we wanted to determine whether anti-T44 mAb could induce modulation of T44 molecules and whether a physical link existed between T44 molecules and the T3-Ti molecular complex. To this end, JA3 cells were incubated for 24 h with antibodies to T3, JTi, or to T44 (to induce antigen modulation) and subsequently stained with each other antibody. Although anti-T44 did not induce a complete modulation of the corresponding molecules in JA3 cells, a strong reduction (-80%) of the T44 expression was observed (Fig. 4) . T3-Ti expression was unchanged after modulation of the T44 molecules. Conversely, as previously shown (40), the expression of T44 was unaffected by modulation of the T3-Ti complex. In these experiments we also investigated the physical relationship between T44 and T11 molecules, in view of the involvement of both these structures in T cell proliferation and lymphokine release. In agreement with a previous report (21 ) , expression oft 11 molecules was not affected by modulation of the T3-Ti complex; moreover, it remained unchanged after modulation of T44 molecules, indicating that T11 and T44 molecules are not physically linked on the T cell surface (data not shown). Given the susceptibility of T44 molecules to antibody-induced modulation and given the functional consequences of T44 triggering, it was important to determine whether T44 molecules were reexpressed at the cell surface soon after modulation or whether, similarly to T3-Ti complex, reexpression occurred after a 48-72 h interval. To this end,JA3 cells were incubated for 24 h with antibodies to T44, T3, or JTi molecules, washed extensively, and cultured in the absence of antibody, before analysis of antigen reexpression at different culture intervals. Neither T3-Ti complex nor T44 were reexpressed during the first 48 h, (i. e., T3 and Ti were undetectable whereas T44 was still reduced by ~80%) as assessed by indirect immunofluorescence and FACS analysis. T44 started to be reexpressed at 72 h and the reexpression was complete at 96 h. Interestingly, reexpression of T44 at the JA3 cell surface paralleled that of T3 and JTi molecules.
To further document that T44 and JTi molecules were neither identical nor physically related, sequential immunoprecipitation experiments were performed. JA3 ceils were surface labeled using lactoperoxidase-catalyzed iodination. After detergent lysis, cell extracts were immunoprecipitated and analyzed by SDS-PAGE. Under reducing conditions (Fig. 5) , the anti-T44-specific immunoprecipitate consisted of M,. 44 K molecules migrating as a broad band (Fig. 5 a) . Under the same conditions, the anti-JTi-specific immunoprecipitate showed three distinct bands of M, 49, 45, and 40 K, respectively (Fig. 5b) . Under nonreducing conditions, the molecules recognized by anti-T44 and anti-JTi4 mAb consisted of a similar 85 K band (data not shown). Preclearing of anti-T44-specific molecules virtually eliminated the reactivity of such antibody for 125I-labeledJA3 cell lysates (Fig. 5 d) but did not affect at all the reactivity of anti-JTi4 mAb (Fig.  5 c) . It must be stressed that absorption experiments using the anti-T44 antibody were performed using twice as much cell lysate with respect to the immunoprecipitations shown in lanes a and b. In addition, preclearing of anti-JTi-specific molecules abrogated the reactivity of anti-JTi antibodies for ~25I-labeledJA3 cell lysates but had no effect on the immunoprecipitation of anti-T44 mAb-reactive molecules (not shown). 
T44 Triggering of IL-2 Production Is Regulated by the T3-Ti Receptor Complex. Since both T 4 4 and T 3 -T i receptor complex triggered IL-2 production
and, m o r e o v e r , both structures were susceptible to antibody-induced modulation, it was important to d e t e r m i n e whether the capacity to trigger via one structure was d e p e n d e n t on the other. T o determine whether anti-T3 or anti-JTi antibodies affected subsequent activation by anti-T44 antibody, and, conversely, whether anti-T44 modulation had any effect on subsequent triggering with anti-T 3 or anti-Ti antibodies, JA3 cells were incubated for 24 b at 37°C with one or a n o t h e r mAb, washed to r e m o v e excess antibody, and stimulated with appropriate concentrations of the various antibodies and PMA. As shown in Table II , preincubation of JA3 cells with anti-T44 antibody virtually abrogated IL-2 production induced by the same antibody, but did not affect the a n t i -T 3 -or a n t i -T i -t r i g g e r e d IL-2 production. In contrast, preincubation with anti-T3 or anti-JTi m A b abrogated IL-2 production triggered by the same antibodies as well as by anti-T44. Similar results were obtained in experiments in which adherent cells (and not PMA) were added to the cultures. Similar experiments designed to analyze the functional consequences of antibody-induced modulation on IL-2 production were p e r f o r m e d with purified (resting) peripheral blood T cells. Cells were preincubated for 48 h with either anti-T44, anti-T3, or anti-T 11 antibody. After extensive washings and FACS analysis, cells were cultured in the presence of one of the antibodies and a d h e r e n t ceils (104/well). T h e 48-b supernatants were assessed for IL-2 activity in the C T L indicator system. Preincubation of T cells with anti-T44 antibody a b r o g a t e d the IL-2 production induced by the same antibody but had no effect on a n t i -T 3 -m e d i a t e d IL-2 production. In contrast, preincubation with anti-T3 antibody abrogated the IL-2 production triggered by anti-T3 or anti-T44 antibody. T h e anti-T11 antibody JA3 cells were incubated for 24 h with one or another mAb as described in Materials and Methods, washed, and subsequently seeded at 1.5 x 105/well in the presence of the various mAb and PMA (10 ng/ml). Supernatants were collected 24 h later and tested for IL-2 activity as described in Materials and Methods. * PMA was added to all cultures. * Anti-JTi4 antibody was added.
Values indicate the arbitrary units of IL-2 per ml.
used as control neither induced modulation of the corresponding molecules nor promoted any detectable IL-2 production by T cells (not shown). Thus, it appears that modulation of the T3-Ti receptor complex, although having no effect on T44 expression at the cell surface, regulated the ability of the T44 structure to induce IL-2 release.
Discussion
In the present report we describe a new pathway of human T lymphocyte activation triggered by the T cell lineage-specific T44 surface molecule after binding to a specific mAb. Some physical and functional characteristics of the T44 molecules appeared similar to those of the T cell receptor molecules, including comparable Mr under both reducing and nonreducing conditions, susceptibility to antibody-induced modulation, and the capability of triggering T lymphocyte proliferation and IL-2 release. A possibility was that anti-T44 antibody recognized a monomorphic determinant of the T cell receptor. However, our present data provide clear evidence that the two surface structures are physically independent. Moreover, we show that T44 molecules are not physically related to the T 11 structure, which is also capable of mediating a T cell activation alternative to that initiated by the T3-Ti receptor complex (21) .
The T44 molecule was expressed in both resting and activated T lymphocytes and in some T celt ieukemias (23), while it was weakly expressed on a subpopulation of thymocytes. In this respect, distribution of T44 molecules differs from that of the M, 50 K T11 or the 40 K 3A1 molecules, which are present on 98% of thymocytes and thus represent early T cell differentiation antigens. In addition, according to Hansen et al. (23) , distribution of the T44 molecules could be distinguished from that of T3 antigen on the basis of differential reactivity with some T cell leukemias.
Similar to anti-T3 or anti-T11, anti-T44 antibody induced both T cell proliferation and IL-2 release. However, whereas T 11 triggering in resting T lympho-cytes could be achieved with antibody in soluble form (21) , triggering of T44 molecule, like that of T3, required the presence of adherent cells. On the other hand, triggering of JA3 cells could be achieved with anti-T44 in absence of PMA or adherent cells, while triggering of JA3 with either anti-T3 or anti-Ti antibody required PMA or adherent cells. In a previous report (25) the same anti-T44 antibody did not induce proliferation of resting T cells. A likely explanation for this discrepancy may be that, in contrast to lymphocyte suspensions used in our study, lymphocytes were nylon wool-passed and therefore depleted of most adherent cells.
We also studied the relationships between T44 molecules and the other monomorphic or clonotypic structures involved in T cell activation, on the JA3 tumor T cell line. JA3 appeared to be particularly suitable for these studies in view of its ability to produce large amounts of IL-2 after appropriate stimuli and because mAb to the JA3 clonotypic structures were available. Antibody-induced antigen modulation experiments showed that T44 molecules, like T3 or Ti, were susceptible to modulation. However, while modulation of T3 or Ti molecules resulted in reciprocal comodulation, it had no effect on T44 surface antigen expression. Moreover, modulation of T44 molecules had no effect on T3, Ti, or T11 antigen expression. These experiments, together with the finding that preclearing 125I-labeled JA3 lysates with anti-T44 did not remove molecules immunoprecipitated by anti-Ti antibodies, and that preclearing with anti-JTi did not remove molecules reactive with anti-T44 mAb, indicate that the T44 molecule is not identical and probably not physically related to the 0e or/3 chains of the T cell receptor. The T cell receptor complex, however, appears to regulate the capacity of the pathway of T cell activation initiated by T44 molecule to induce T cell responses. This conclusion is based on the observation that modulation of T3 or Ti molecules leads to inhibition of T cell response to anti-T44 antibody. A similar dependency upon the T3-Ti antigen receptor complex has been described by Meuer et al. (21) for the T11-dependent pathway of T cell activation. Study of the functional correlation between these two antigenindependent pathways of T cell activation could not be carried out because antiTll mAb with stimulatory capacity were not available in our lab; however, modulation experiments indicated that T44 and T11 molecules were not physically linked at the cell surface.
The T44 pathway of T cell activation may be triggered by a still undefined natural ligand. It cannot be excluded that the T44 molecule itself may be important for cell-to-cell contacts, as suggested by preliminary experiments in which anti-T44 antibody had a strong inhibitory activity on specific target cell lysis mediated by alloreactive cytolytic cells. Whatever the natural ligand of T44 molecule may be, the late reexpression of this molecule after antibody-induced modulation is strikingly similar to that of the T3-Ti antigen receptor complex. This latency will likely be important for the regulation of the T44-triggered pathway of T cell activation. Future studies characterizing the relationship of the T3-Ti antigen receptor complex and the T44 molecule, by the study of T44-mutants of JA3 similar to the Ti-mutants described by Weiss and Stobo (6), should better define the relative function and behavior of these surface molecules.
Summary
Prior studies indicate that the 9.3 monoclonal antibody (mAb) which defines a 44 kD T lineage-specific glycoprotein (T44) enhances the proliferative response of peripheral blood T lymphocytes to phytohemagglutinin (PHA) or allogeneic cells. The T44 molecule was expressed in both resting and activated T lymphocytes and in a subset of thymocytes, as assessed by indirect immunofluorescence and flow cytofluorometry. In view of the potential importance of T44 in T cell activation, we investigated the ability of the 9.3 (anti-T44) antibody to stimulate peripheral blood T lymphocytes under culture conditions giving optimal proliferative responses to anti-T3 mAb. Like UCHT1 (anti-T3) mAb, the 9.3 (anti-T44 mAb) promoted strong proliferative responses of purified T cells, provided that adherent cells were added to the culture. Maximal proliferation in response to 9.3 antibody was consistently detected at day 5 (at day 3 with anti-T3 or PHA). Moreover, triggering of T lymphocytes with 9.3 antibody (in the presence of adherent cells) resulted in strong IL-2 production that peaked at 48 h. Analysis of the physical and functional relationship between the T44 molecule and other molecules involved in T cell activation, including the clonotypically restricted Ti and the monomorphic T3 or T11 molecules, was carried out on a mutagenized Jurkat T leukemia cell line. This mutant, termed JA3 (surface phenotype: T11 +, T3 +, 3A1 +, T4-, T8-, DR-, Tac-, 4F2 +, T44 +) produced large amounts of IL-2 upon stimulation with PHA, anti-T3, or anticionotypic mAb in conjunction with phorbol myristate acetate (or adherent cells). The molecules precipitated by anti-T44 mAb from 125I-labeled JA3 cells appeared as a diffuse band of Mr 40-45,000 under reducing conditions; under nonreducing conditions, a prominent band of Mr 80-85,000 was observed, while the Mr 40-45,000 band was greatly reduced. Thus, T44 molecules in both reducing and nonreducing conditions had relative molecular weights similar to that of molecules carrying clonotypic (Ti) determinants. In addition, like anti-Ti or anti-T3 mAb, anti-T44 antibody induced JA3 cells to produce large amounts of IL-2 in the presence of phorbol myristate acetate. Other similarities between T44 and molecules carrying clonotypic structures included the susceptibility to antibodyinduced modulation and the late reexpression (72 h) at the cell surface after modulation. Taken together, these experiments suggest that anti-T44 mAb might recognize a monomorphic determinant of the T cell receptor molecule or be physically or functionally linked to the T3-Ti complex. However, antibodyinduced modulation ofT44 molecules did not lead to the loss ofT3, Ti, or T11 molecules, nor did modulation of T3 or Ti affect the expression of T44 antigen at the JA3 cell surface. In addition, sequential immunoprecipitation experiments showed that preclearing of JA3 cell lysates with anti-T44 antibody did not remove molecules carrying clonotypic structures, and that preclearing with anticlonotypic mAb did not affect subsequent precipitation with anti-T44 mAb. Thus, the antigen-independent, T44-mediated mode of T cell triggering is distinct from that initiated by the T3-Ti antigen receptor complex or by T11 molecules. However, modulation of the T3-Ti receptor complex, although it had no effect on T44 expression, did regulate the ability of T44 molecules to induce IL-2 release. The nature of the natural ligand of T44 molecule and the role in vivo of T44-triggered pathway of human T cell activation remains to be determined.
